• Journal of Microbiology and Biotechnology
• /
• 제20권10호
• /
• pp.1367-1377
• /
• 2010

Scientific research regarding the use of live bacterial cells for therapeutic purposes has been rapidly growing over the years and has generated considerable interest to scientists and health professionals. Probiotics are defined as essential live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. Owing to their considerable beneficial health effects, these microorganisms are increasingly incorporated into dairy products; however, many reports have demonstrated their poor survival and stability. Their survival in the gastrointestinal tract is also questionable. To overcome these problems, microencapsulation techniques are currently receiving considerable attention. This review describes the importance of live probiotic bacterial microencapsulation using an alginate microparticulate system and presents the potentiality of various coating polymers such as chitosan and polylysine for improving the stability of this microencapsulation.

• Journal of Dairy Science and Biotechnology
• /
• 제26권2호
• /
• pp.31-37
• /
• 2008

One hundred one years have passed since Metchnikoff made his first scientific contribution to probiotics study. Intestinal lactic acid bacteria (LAB) for humans are closely associated with the host's health because LAB is an important biodefense factor in preventing colonization and subsequent proliferation of pathogenic bacteria in the intestine. A probiotic is recently defined as "live microorganisms that when administered in adequate amount confer a health benefit on the host". Some species of LAB have been claimed as probiotics, such as Lactobacillus acidophilus, L. casei, L. fermentum, L. plantarum, L. reuteri, and Lactococcus lactis. For understanding the general mechanism of probiotics, this paper would explore the early studies relating to probiotics and intestinal microbiota, and briefly introduce the Prolongation of Life written by Elie Metctmikoff.

• 한국미생물·생명공학회지
• /
• 제48권3호
• /
• pp.276-286
• /
• 2020

Probiotics are live microorganisms that, when administered in adequate amounts, confer health benefits to the host. This study was conducted for the isolation of potential lactic acid bacteria (LAB) with probiotic properties from goat milk and yogurt. Several tests were conducted in vitro using the standard procedures for evaluating the inhibitory spectra of LAB against pathogenic bacteria; tolerance to NaCl, bile salt, and phenol; hemolytic, milk coagulation, and bile salt hydrolase activities; gastrointestinal transit tolerance; adhesion properties; and antibiotic susceptibility. Among 40 LAB strains screened according to culture characteristics, five isolates exhibited antagonistic properties. Three were identified as Pediococcus acidilactici, and two were identified as Enterococcus faecium, exploiting 16S rRNA gene sequencing. All the isolates succeeded in the gastrointestinal transit tolerance assay and successively colonized mucosal epithelial cells. Based on the results of these in vitro assays, both P. acidilactici and E. faecium can be considered as potential probiotic candidates.

• KSBB Journal
• /
• 제25권4호
• /
• pp.303-310
• /
• 2010

프로바이오틱스는 위장관에서 고유의 생리활성을 발휘하기 때문에 섭취 후 최대한 장까지 사멸하지 않고 도달하도록 하는 코팅이나 encapsulation 기술이 개발되어 왔다. 이와 함께 제품의 형태도 여러 종류의 유산균이 포함된 multispecies probiotics가 선호되는 추세이며 높은 생균수를 가지는 제품들이 개발되고 있다. 프로바이오토틱 시장은 현재까지 생균 중심의 제품들이 대부분을 차지하고 있으나 사균체 제품 또는 박테리오신과 같은 항균물질을 포함하는 제품 또한 다양한 분야에 적용될 수 있고 생균제와 비교하여 여러가지 장점을 가지고 있어 관련 제품개발이 이루어져야 할 것으로 보인다. 프로바이오틱 제품들은 살아 있는 생균제로서 질환특이적 효능을 바탕으로 개발되고 있으나 질환개선 효능 표시에 대한 규제가 강화되고 있어 이에 대한 대비가 필요하다. 이를 위해 제품에 사용된 strain의 동정, 안전성 및 기능성에 대한 과학적 증거가 제시되어야 할 것이며 임상을 통한 안전성과 효능에 대한 검증 자료가 필요할 것으로 보인다. 이와 같은 프로바이오틱스 제품의 헬스클레임에 대한 엄격해진 검증은 앞으로 프로바이오틱 시장에 큰 영향을 미칠 것으로 판단된다.

• Journal of Microbiology and Biotechnology
• /
• 제31권7호
• /
• pp.999-1010
• /
• 2021

Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous in the environment. They are highly toxigenic and carcinogenic. Probiotic bacteria isolated from fermented foods were tested to check their ability to degrade and/or detoxify PAHs. Five probiotic bacteria with distinct morphologies were isolated from a mixture of 26 fermented foods co-cultured with benzo(a)pyrene (BaP) containing Bushnell Haas minimal broth. Among them, B. velezensis (PMC10) significantly reduced the abundance of BaP in the broth. PMC10 completely degraded BaP presented at a lower concentration in broth culture. B. velezensis also showed a clear zone of degradation on a BaP-coated Bushnell Haas agar plate. Gene expression profiling showed significant increases of PAH ring-hydroxylating dioxygenases and 4-hydroxybenzoate 3-monooxygenase genes in B. velezensis in response to BaP treatment. In addtion, both live and heat-killed B. velezensis removed BaP and naphthalene (Nap) from phosphate buffer solution. Live B. velezensis did not show any cytotoxicity to macrophage or human dermal fibroblast cells. Live-cell and cell-free supernatant of B. velezensis showed potential anti-inflammatory effects. Cell-free supernatant and extract of B. velezensis also showed free radical scavenging effects. These results highlight the prospective ability of B. velezensis to biodegrade and remove toxic PAHs from the human body and suggest that the biodegradation of BaP might be regulated by ring-hydroxylating dioxygenase-initiated metabolic pathway.

• Journal of Microbiology and Biotechnology
• /
• 제32권7호
• /
• pp.877-884
• /
• 2022

Probiotics are microorganisms that can benefit host health when ingested in a live state, and lactic acid bacteria are the most common type. Among fungi, Saccharomyces boulardii (SB) is the only strain known to have a probiotic function with beneficial effects on colitis; however, information on other probiotic yeast strains is limited. Therefore, this study aimed to discover yeast strains expressing intestinal anti-inflammatory activities by exhibiting probiotic properties in dextran sodium sulfate (DSS)-induced colitis mice model. Nuruk (Korean traditional fermentation starter) containing various microbial strains was used as a source for yeast strains, and S. cerevisiae 28-7 (SC28-7) strain was selected with in vitro and in vivo characteristics to enable survival in the intestines. After 14 days of pretreatment with the yeast strains, DSS was co-administered for six days to induce colitis in mice. The results revealed that the disease activity index score was lowered by SC28-7 treatment compared to the DSS group, and the colon length and weight/length ratio were recovered in a pattern similar to that of the normal group. SC28-7 administration significantly reduced the secretion of pro-inflammatory cytokines in the serum and modified the mRNA expression of inflammatory cytokines (interleukin-1β, transforming growth factor-β, and interferon-γ) and proteins involved in gut barrier functions (mucin 2, mucin 3, zonula occludens-1, and occludin) in colon tissues. These results indicate that SC28-7 attenuates DSS-induced colon damage and inflammation, supporting its future use as a probiotic yeast for treating and preventing intestinal inflammatory diseases such as inflammatory bowel disease.

• 한국미생물·생명공학회지
• /
• 제49권2호
• /
• pp.157-166
• /
• 2021

The probiotic market is constantly continuing to grow, concomitantly with a widening in the range and diversity of probiotic products. Probiotics are defined as live microorganisms that provide a benefit to the host when consumed at a proper dose; the viability of a probiotic is therefore of crucial importance for its efficacy. Many products undergo lyophilization for maintaining their shelf-life. Unfortunately, this procedure may damage the integrity of the cells due to stress conditions during both the freezing and (vacuum-) drying process, thereby impacting their functionality. We propose a lysine-based mixture for rehydration of freeze-dried probiotics for improving their viability during in vitro simulated gastric and duodenum stress conditions. Measurement of the zeta potential served as an indicator of cell integrity and efficacy of this mixture, while functionality was estimated by adhesion to a human enterocyte-like Caco-2 cell-line. The freeze-dried bacteria exhibited a significantly different zeta potential compared to fresh cultures; however, this condition could be restored by rehydration with the lysine mixture. Recovery of the surface charge was found to influence adhesion ability to the Caco-2 cell-line. The optimum lysine concentration of the formulation, designated "Zeta-bio", was found to be 0.03 M for improving the viability of Lactiplantibacillus plantarum Lp-115 by up to 13.86% and a 7-strain mixture (400B) to 41.99% compared to the control rehydrated with distilled water. In addition, the lysine Zeta-bio formulation notably increased the adherence ability of lyophilized Lp-115 to the Caco-2 cell-line after subjected to the in vitro stress conditions of the simulated gastrointestinal tract passage.

• Reproductive and Developmental Biology
• /
• 제34권4호
• /
• pp.299-304
• /
• 2010

To identify the treatment effect of lactic acid bacteria for diabetes, the treatment effects of a single administration of acarbose (a diabetes treatment drug) or lactic acid bacteria, and the mixture of acarbose and lactic acid bacteria on diabetes in a type 1 diabetes animal model, were studied. In this study, streptozotocin was inoculated into a Sprague-Dawley rat to induce diabetes, and sham control (Sham), diabetic control (STZ), STZ and composition with live cell, STZ and composition with heat killed cell, STZ and composition with drugs (acarbose) were orally administered. Then the treatment effect on diabetes was observed by measuring the body weight, blood glucose, and serum lipid. For the histopathological examination of the pancreas, the Langerhans islet of the pancreas was observed using hematoxylin and eosin staining, and the renal cortex, outer medullar, and inner medullar were also observed. The induced diabetes decreased the body weight, and the fasting blood glucose level decreased in the lactic-acid-bacteria-administered group and the mixture-administered group. In addition, the probiotic resulted in the greatest decrease in the serum cholesterol level, which is closely related to diabetes. Also, the hematoxylin and eosin staining of the Langerhans islet showed that the reduction in the size of the Langerhans islet slowed in the lactic-acid-bacteria-administered group. The histopathological examination confirmed that the symptoms of diabetic nephropathy decreased in the group to which viable bacteria and acarbose were administered, unlike in the group to which dead bacteria was administered. The mixture of lactic acid bacteria and acarbose and the single administration of lactic acid bacteria or acarbose had treatment effects on the size of the Langerhans islet and of the kidney histopathology. Thus, it is believed that lactic acid bacteria have treatment effects on diabetes and can be used as supplements for the treatment of diabetes.

• Toxicological Research
• /
• 제30권1호
• /
• pp.27-32
• /
• 2014

Probiotics are live microorganisms that confer a health benefit on the host. Duolac-Gold is a mixture of seven probiotic bacteria containing three species of Bifidobacteria, two species of Lactobacillus, and Streptococcus thermophilus. The aim of this study was to assess the anti-inflammatory effects of Duolac-Gold in an inflammatory bowel disease (IBD) mouse model. IBD was induced by administering 1.5% dextran sulfate sodium (DSS) for 10 days. After induction of DSS-induced colitis, Duolac-Gold was orally administered at three different concentrations. Interestingly, Duolac-Gold treatment accelerated IBD healing, and anti-inflammatory activity was assessed by weight loss, length of the colon, and a microscopic damage score by histology. The expression of inflammatory related cytokines was measured in colon tissues and serum. Of these cytokines, the expression of interleukin-6 decreased remarkably after Duolac-Gold treatment. Taken together, these results suggest that Duolac-Gold treatment is effective in IBD healing by regulating IL-6.

• 한국가금학회지
• /
• 제40권1호
• /
• pp.57-65
• /
• 2013

김치의 주종 유산균의 하나인 Weissella koreensis(Wk)의 육계 사료용 probiotics로서 활용 가능성을 평가하기 위하여 육계 성장능력, 영양소 이용률, 면역능력, 장내 미생물, 계육품질에 미치는 영향을 평가하였다. 무첨가 육계사료를 대조구(Control)로 설정하고, 처리구로 생균 형태의 Wk를 0.1%(LWk 0.1), 0.5%(LWk 0.5) 첨가한 구와 사균 형태의 Wk 0.5%를 첨가한 구(KWk 0.5) 등 총 4처리를 두었다. 본 연구결과, 생균 형태의 LWk 첨가는 대조구와 사균 형태의 첨가구(KWk 0.5)에 비하여 증체율과 사료 효율을 유의적으로 개선시켰다. 영양소 이용률은 처리구 간에 차이가 없었으나, 조단백질 이용률이 사균(KWk 0.5) 첨가구에서 유의적으로 낮았다. 혈청 IgG 수준과 F낭의 상대적 크기는 KWk 0.5 첨가구가 가장 높았다. 생균 형태의 Wk 첨가로 맹장 내 총 혐기성 유산균의 수가 유의적으로 높아졌으나, 대장균의 수에는 변화가 없었다. 사료 내 김치유산균의 첨가는 생균이나 사균 모두 계육 지방산 조성, 계육의 산패 지연에는 영향을 나타내지 못하였다. 그러나 생균이나 사균, 첨가수준 모두가 전자코를 통한 육향에서는 차이를 나타내었다. 본 연구는 생균 형태 Wk가 육계 사료용 생균제로 활용 가능함을 보여주었다.